How do I choose between Cyberknife (S... - Fight Prostate Ca...

Fight Prostate Cancer

2,956 members1,313 posts

How do I choose between Cyberknife (SBRT) monotherapy vs HDR Brachytherapy+EBRT?

FiguringOut profile image
2 Replies

M59, Gleason 4+3 (second opinion confirmed by Jonathan Epstein at John Hopkins), PSA7.8 average past 1 year, T2C stage. Haven't been operated or radiated before.

Currently am being offered:

1) 5 fraction Cyberknife (SBRT) therapy that is concentrated to the prostate.

2) 1 time high dose rate Bracytherapy combined with 5 week EBRT radiation therapy.

None of docs believe ADT is necessary as of now.

I can't make the choice.

On one hand, SBRT efficacy is often compared with level of Bracyhtherapy.

It is apparently very similar in results, but I'm worried if Brachy+EBRT won't be way more effective ensuring that pelvic lymph nodes are also captured in the beam?

After all my case has a rather high recurrence rate after Radical Prostatectomy according to nonograms, however if lymph nodes are radiated, doesn't that lower the risk dramatically?

And how can Cyberknife compared in efficacy when it radiates only the prostate?

There are some talks that SBRT high dose radiation is more effective in killing cancer, but it can't kill mets outside prosate, can it now? While EBRT can.

Cyberknife would be ideal solution and its close to home. Brachy+EBRT requires 5 week living in another country.

What do you think, which case would you choose in my situation?

Pros and cons of each?

What do you think of met risks with Cyberknife?

Written by
FiguringOut profile image
FiguringOut
To view profiles and participate in discussions please or .
Read more about...
2 Replies
NPfisherman profile image
NPfisherman

So what does your doctor recommend?? You can get a second opinion also...

FiguringOut profile image
FiguringOut in reply toNPfisherman

My doc says everything is on the plate: surgery, external beam, internal radiation. Up to me.

Not what you're looking for?

You may also like...

Understanding the differences in types of radiation and why the ORIOLE Trial showed SBRT to be effective for Oligometastatic patients

Hello FPC crew, Not to be confused with 2 Live Crew...Recently, a post appeared on another forum...
NPfisherman profile image

SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic PCa - ARTO II~ Improved response & PFS compared to SOC, MedPage Today, 09/27/23

SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer — Combination...
cujoe profile image

Finally Undetectable PSA on BAT

Happy to share my latest progress report. Note that I am mHSPC, lymph nodes only to pelvis and...
MateoBeach profile image

EMBARK Study: Enzalutamide +/- ADT

Results of the EMBARK study was published this week (10/19/23) in NEJM. It compared high risk BCR...

Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer

Doctors in Perth, Australia are leading a Phase 3 clinical trial called ProstACT GLOBAL, which is...
Maxone73 profile image